Literature DB >> 21116300

Kidney cancer: Does hypothyroidism predict clinical outcome?

Brian Rini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21116300     DOI: 10.1038/nrurol.2010.191

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  6 in total

1.  Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.

Authors:  Brian I Rini; Ila Tamaskar; Phillip Shaheen; Renee Salas; Jorge Garcia; Laura Wood; Sethu Reddy; Robert Dreicer; Ronald M Bukowski
Journal:  J Natl Cancer Inst       Date:  2007-01-03       Impact factor: 13.506

2.  Hypothyroidism in patients with renal cell carcinoma: blessing or curse?

Authors:  Manuela Schmidinger; Ursula M Vogl; Marija Bojic; Wolfgang Lamm; Harald Heinzl; Andrea Haitel; Martin Clodi; Gero Kramer; Christoph C Zielinski
Journal:  Cancer       Date:  2010-09-15       Impact factor: 6.860

3.  Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma.

Authors:  Robert J Motzer; Jennifer Bacik; Barbara A Murphy; Paul Russo; Madhu Mazumdar
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

4.  Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib.

Authors:  I Tamaskar; R Bukowski; P Elson; A G Ioachimescu; L Wood; R Dreicer; T Mekhail; J Garcia; B I Rini
Journal:  Ann Oncol       Date:  2007-10-24       Impact factor: 32.976

5.  Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.

Authors:  Daniel Y C Heng; Wanling Xie; Meredith M Regan; Mark A Warren; Ali Reza Golshayan; Chakshu Sahi; Bernhard J Eigl; J Dean Ruether; Tina Cheng; Scott North; Peter Venner; Jennifer J Knox; Kim N Chi; Christian Kollmannsberger; David F McDermott; William K Oh; Michael B Atkins; Ronald M Bukowski; Brian I Rini; Toni K Choueiri
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

6.  Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: a prospective evaluation.

Authors:  Hideaki Miyake; Toshifumi Kurahashi; Kazuki Yamanaka; Yutaka Kondo; Mototsugu Muramaki; Atsushi Takenaka; Taka-Aki Inoue; Masato Fujisawa
Journal:  Urol Oncol       Date:  2009-11-13       Impact factor: 3.498

  6 in total
  1 in total

1.  Thyroid dysfunction in patients treated with sunitinib or sorafenib.

Authors:  Julia Clemons; Dexiang Gao; Mary Naam; Kathryn Breaker; David Garfield; Thomas W Flaig
Journal:  Clin Genitourin Cancer       Date:  2012-09-25       Impact factor: 2.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.